Adhesion Barriers Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

The global adhesion barriers market was valued at USD 1.05 billion in 2025. It is poised to grow at a CAGR of 7.60% during the forecast period of 2026-2035, and reach USD 2.19 billion by 2035. The growth is supported by rising global surgical volumes and increasing clinical adoption of synthetic, hyaluronic acid-based, and starch-based adhesion barriers across gynaecological, abdominal, cardiovascular, and neurological procedures worldwide.

Latest News on the Adhesion Barriers Market (2026)

April 2026: Baxter Expands Surgical Portfolio With Improved Adhesion Prevention Technology

According to MedTech Dive, Baxter International continues expanding its advanced surgery portfolio in 2026 following the closed USD 350 million acquisition of Sanofi's Seprafilm Adhesion Barrier and related assets. The integration accelerates Baxter's premium-segment positioning across abdominal and gynecological surgery, reinforcing competitive dynamics with Johnson and Johnson, Becton Dickinson, and Anika Therapeutics across the global adhesion barriers market.

March 2026: Adhesion Barrier Market Set to Cross 1.86 Billion by 2035

According to Baxter, the adhesion barrier category continues maturing in 2026 with rising surgical volumes and growing post-operative care expectations, supporting Baxter's strategic expansion of Seprafilm's commercial footprint. Increasing adoption of advanced biomaterials in abdominal and gynecological surgery is reinforcing premium-segment positioning and durable growth across the global adhesion barriers market amid rising orthopedic and cardiovascular procedure volumes.

Key Market Trends and Insights

• By product, the synthetic adhesion barriers held nearly 53% market share in the historical period.
• By formulation, the film/mesh segment accounted for approximately 44% market share in the historical period.
• By application, the gynaecological surgeries segment is expected to lead the market in the forecast period.

Market Size and Forecast

• Market Size (2025): USD 1.05 billion
• Projected Market Size (2035): USD 2.19 billion
• CAGR (2026-2035): 7.60%
• Largest Regional Market in 2025: North America

Adhesion Barriers Market Overview

Adhesion barriers are biocompatible, bioresorbable medical devices, including films, gels, and liquids, placed between tissues during surgery to physically separate organs and prevent post-operative scar tissue formation. They reduce risks of chronic pain, infertility, and bowel obstruction following abdominal, pelvic, cardiac, neurological, and orthopaedic procedures. The market was valued at USD 1.05 billion in 2025 and is poised to grow at a CAGR of 7.60%. Post-operative adhesions occur in most of the surgeries, sustaining a steady demand for advanced adhesion prevention solutions across hospitals and ambulatory surgical centres globally.

Adhesion Barriers Market Growth Drivers

Rising Surgical Volumes to Boost Adhesion Barriers Market Expansion

The growing global volume of surgical procedures is the leading driver of demand for adhesion barriers. According to the World Health Organization, surgical care is an indivisible component of universal health coverage, with hundreds of millions of major operations performed each year. As per Robert J Morris et al., 2024, post-operative adhesions occur in over 90% of all open gynaecologic and abdominal surgeries, generating multi-billion-dollar annual healthcare costs. This sustained clinical and economic burden underpins steady demand for film, gel, and liquid adhesion barriers.

Adhesion Barriers Market Trends

Some of the trends in the market include rising innovations in advanced adhesion barrier formulations and technologies.

Growing Innovation and Long-Term Clinical Validation of Anti-Adhesion Barriers is Likely to Enhance Market Growth

The increasing focus on innovation and long-term clinical validation of anti-adhesion barrier products is emerging as a key trend in the market. Companies are emphasizing product differentiation through advanced formulations and proven safety profiles to strengthen adoption across surgical specialties. For instance, in May 2025, Genewel and Hanmi Science highlighted the 20-year clinical success of Guardix®, reinforcing its effectiveness and expanding global ambitions. This trend is expected to significantly enhance overall market growth.

Adhesion Barriers Market Segmentation

Market Breakup by Type

• Seprafilm
• Gynecare Interceed
• Adept
• Duragen Plus
• MediShield
• Oxiplex
• SprayShield
• 4DryFieldPH
• Hyalobarrier
• Others

Market Breakup by Formulation

• Film
• Gel
• Liquid

Market Breakup by Application

• Gynaecological Surgeries
• Abdominal General Surgeries
• Orthopaedic Surgeries
• Cardiovascular Surgeries
• Neurological Surgeries
• Urological Surgeries
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Adhesion Barriers Market Share

Film and Mesh Formulations to Lead the Market by Formulation

The market is segmented by formulation into film/mesh, gel, and liquid adhesion barriers, each offering distinct handling characteristics and clinical benefits. Among these, film and mesh formulations are expected to lead the market due to their ease of application, precise placement, and effectiveness in creating a physical barrier during surgical procedures. Their widespread adoption in abdominal and gynecological surgeries, along with consistent clinical performance and surgeon preference for reliable adhesion prevention, continues to drive segment growth.

Adhesion Barriers Market Regional Analysis

North America is expected to dominate the market, supported by high surgical volumes, advanced healthcare infrastructure, strong reimbursement frameworks, and widespread adoption of innovative adhesion prevention products. Additionally, the presence of leading market players and continuous technological advancements in surgical care further strengthen regional growth. Europe follows with steady adoption driven by value-based healthcare systems, while Asia Pacific is witnessing rapid expansion due to increasing healthcare investments and rising surgical procedures.

Leading Players in the Adhesion Barriers Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Johnson & Johnson

Johnson & Johnson plays a significant role in the adhesion barriers market through its GYNECARE INTERCEED™ Absorbable Adhesion Barrier, a regenerated cellulose-based device designed for gynecologic surgeries. The product reduces postoperative adhesion formation by separating tissue surfaces during healing. With strong clinical evidence and long-term use, the company continues to support improved surgical outcomes and cost efficiency in adhesion prevention.

Baxter International Inc.

Baxter, headquartered in Deerfield, Illinois, supplies the Seprafilm Adhesion Barrier across the United States, Japan, China, South Korea, and France. Baxter expanded its polyethylene glycol-based hydrogel adhesion barrier portfolio with new formulations for laparoscopic and robotic-assisted surgeries, reinforcing leadership in advanced surgical care globally.

Betatech Medical Ltd. Sti.

Betatech Medical Ltd. Sti. is a medical device manufacturer specializing in surgical solutions, including adhesion prevention products. Its Betamix Adhesion Barrier Gel is a flowable, bioresorbable gel designed to reduce post-surgical adhesions by forming a temporary protective barrier between tissues. The company actively supports surgical care through its adhesion prevention portfolio, contributing to improved clinical outcomes and expanding its presence in the adhesion barrier market.

BiosCompass, Inc.

BiosCompass, Inc. is a biomedical company focused on surgical adhesion prevention through its AntiAD© product portfolio. Its specialized gels, including AntiAD© TN, SP, AP, and OT, are designed for tendon, spine, abdominal-pelvic, and orthopedic applications. These solutions support post-operative healing by minimizing adhesion formation, strengthening the company’s role in advancing innovation within the market.

Other key players in the market are FzioMed, Inc., AlloSource Inc., Mast Biosurgery, Inc., Terumo Corporation, Becton Dickinson and Company, and Integra LifeSciences Holdings Corporation.

Key Questions Answered in the Adhesion Barriers Market Report

• What was the adhesion barriers market value in 2025?
• What is the adhesion barriers market forecast outlook for 2026-2035?
• What major factors aid the demand for the adhesion barriers market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major adhesion barriers market trends?
• Which product is expected to dominate the market segment?
• Which formulation is projected to lead the market segment?
• Which application is anticipated to drive the market segment?
• Which end user is anticipated to lead the global adhesion barriers market?
• Who are the key players in the adhesion barriers market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?